U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07645235) titled 'A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Women' on June 08.

Brief Summary: This study aims to evaluate the pharmacokinetic of gepotidacin in fed healthy lactating women.

Study Start Date: July 09

Study Type: INTERVENTIONAL

Condition: Urinary Tract Infections

Intervention: DRUG: Gepotidacin

A single oral dose of 3000 mg gepotidacin will be administered

Recruitment Status: NOT_YET_RECRUITING

Sponsor: GlaxoSmithKline

Disclaimer: Curated by HT Syndication....